Decentralized Clinical trials have become increasingly prevalent in the biotech and biopharmaceutical industries.
Decentralized Clinical trials have become increasingly prevalent in the biotech and biopharmaceutical industries. Experts suggest the value of DCTs will increase by 9.8% between 2023 to 2029. Decentralized Clinical trials are cost effective and offer many benefits to researchers and participants alike, which is likely the cause of their increased usage. However, there are also some risks involved. To address this, the FDA released draft guidance to regulate DCTs and ensure participant privacy and data is protected. The guidance covers data collection and storage, investigator and sponsor responsibilities, and more.
DISCOVER MORE
Regulating AI in Clinical Trials: What ICH E6(R3) Does (and Doesn’t) Say
Despite AI’s growing role in clinical trials, ICH E6(R3) remains silent—does this leave room for innovation or uncertainty?
Explores the Differences Between Auditors and Inspectors in the Clinical Research Industry
Despite similarities and differences in their roles, both auditors and inspectors play an important part in ensuring compliance.
Competency Based Programs Contribute to Early Clinical Research Professional’s Training
Explore the benefits of on-the-job training for Clinical Research Professionals
15 Years of Excellence: FDAQRC's Journey and Future Vision
Marking a milestone of 15 years, FDAQRC continues to grow with expanded global services, innovative partnerships, and steadfast commitment to quality and compliance.
Tips for a Positive Outcome While Performing a Challenging Audit
Transform a daunting audit into an opportunity for improvement with strategies to de-escalate tensions and foster collaboration
How To Find Qualified Patients for Your Clinical Trials
Streamline patient recruitment and match participants to your specific research criteria with Quri.AI’s advanced AI-driven solutions. Save time, reduce costs, and enhance the success of your clinical trials.
Simplified SOPs Can Reduce FDA Citations and Enhance Compliance Culture
Failure to fully adhere to Standard Operating Procedures (SOPs) is a leading cause of FDA warning letters, with over half of the citations issued annually addressing this concern.
Creating a Supportive Workplace: Recognizing and Addressing Mental Health
Fostering well-being in the workplace involves raising awareness and encouraging self-care. Implementing strategies to prevent burnout and support mental health is essential for a positive, inclusive environment..